India gears up for patient trials on 20 different drugs for Covid-19

Local pharma units have already started work on developing patented drugs, some have already approached regulator for approvals

In the search for a potential line of treatment, India is lining up patient trials on about 20 different drugs, which include patented anti-viral drugs like Favipiravir. Local pharma companies have already started developing patented drugs, and some have approached the country's drug regulator for approvals.
 

Apart from anti-virals, drugs such as Sepsivac (used for blood poisoning or sepsis) and Interferon alpha 2b (a biologic) will soon be used in patient trials. A government official noted that different drugs are being considered including anti-virals. Some of these trials will be conducted by companies, while other by the government.
 

The key